Florida State University Psychology Department
Tallahassee, Florida, 32304, United States
NCT Number: NCT02635152
The purpose of this study is to determine whether a computerized intervention designed to reduce appearance and evaluation related interpretation biases will reduce symptoms associated with body dysmorphic disorder.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Tallahassee, Florida, 32304, United States
The present study aims to examine the feasibility of a remote treatment for body dysmorphic disorder delivered via the Internet. To evaluate the efficacy of the IBM protocol we have developed in reducing negative appearance and evaluative related interpretations, we will conduct a two-arm randomized controlled trial over the internet. Individuals with a diagnosis of body dysmorphic disorder (N = 40) will be randomized to one of two conditions: 1) IBM or 2) progressive muscle relaxation. Each condition will consist of eight 10-25 minute treatment sessions. Participants will complete two sessions per week for four weeks and will be administered assessments at pre-treatment, one week post-treatment and at 3-month follow-up. We hypothesize that: 1) IBM will lead to greater reductions in BDD symptoms than the PMR condition; 2) IBM will lead to greater reductions in depression, anxiety and suicidal ideation than the PMR condition; 3) IBM will lead to greater reductions in threat interpretations and greater increases in benign interpretations than the PMR condition; 4) The effects of condition on BDD symptoms will be mediated by changes in BDD-related interpretation bias; and 5) The effects of training in the IBM condition will be maintained at the 3-month follow-up assessments.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Eight 10-25 minute sessions of interpretation modification to reduce negative interpretation biases related to appearance.
Eight 15-minute sessions of progressive muscle relaxation (PMR).
Time frame: change from baseline at one-week post treatment and 3-months post-treatment
Measures past-week BDD symptom severity
Time frame: change from baseline at one-week post treatment and 3-months post-treatment
Measures depressive symptom severity
Time frame: change from baseline at one-week post treatment and 3-months post-treatment
Measure anxious symptom severity
Time frame: change from baseline at one-week post treatment and 3-months post-treatment
Measure severity of recent suicidality
Time frame: change from baseline at one-week post treatment and 3-months post-treatment
Measure of strength of BDD-related (i.e. evaluation- and appearance- related threat interpretation biases)
Florida State University
Other
Evaluation of an Internet-Based Treatment for Body Dysmorphic Disorder
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07036744
Body Dysmorphic Disorder, Body Dysmorphic Disorders
Coimbra, Coimbra District, Portugal
View Trial DetailsNCT00106223
Body Dysmorphic Disorder, Body Dysmorphic Disorders
Charlestown, Massachusetts, United States
View Trial DetailsNCT07016204
Body Dysmorphic Disorder, Body Dysmorphic Disorders
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06896435
Anxiety Disorders, Body Dysmorphic Disorder
Tallahassee, Florida, United States
View Trial Details